Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prognostic Role of Positron Emission Tomography and Computed Tomography Parameters in Stage I Lung Adenocarcinoma

NCT04202614 is registered in ClinicalTrials.gov with IRCCS San Raffaele as lead sponsor.

NCT NCT04202614
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04202614 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prognostic Role of Positron Emission Tomography and Computed Tomography Parameters in Stage I Lung Adenocarcinoma
Lead sponsor
IRCCS San Raffaele
Phase
Observational
Overall status
Completed
Start date
December 2, 2019
Completion date
January 31, 2020
Enrollment
58 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

stage i pulmonary adenocarcinoma